tranexamic acid has been researched along with Placenta Praevia in 7 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effect of adjunctive intravenous tranexamic acid (TA) on blood loss during cesarean section (CS) in patients with placenta previa undergone bilateral uterine arteryligation (BUAL)." | 9.30 | Bilateral uterine artery ligation plus intravenous tranexamic acid during cesarean delivery for placenta previa: a randomized double-blind controlled trial. ( Abbas, AM; Sallam, HF; Shady, NW, 2019) |
| "Placenta previa affects approximately 4 per 1000 pregnancies and increases the risk of antepartum bleeding, emergent preterm labour and emergency caesarean sections." | 5.91 | Use of tranexamic acid (TXA) to reduce preterm birth and other adverse obstetrical outcomes among pregnant individuals with placenta previa: a systematic review protocol. ( Muldoon, KA; Seguin, N; Visintini, S; Walker, M, 2023) |
| "To investigate the effect of adjunctive intravenous tranexamic acid (TA) on blood loss during cesarean section (CS) in patients with placenta previa undergone bilateral uterine arteryligation (BUAL)." | 5.30 | Bilateral uterine artery ligation plus intravenous tranexamic acid during cesarean delivery for placenta previa: a randomized double-blind controlled trial. ( Abbas, AM; Sallam, HF; Shady, NW, 2019) |
| " A rapid recourse to prostaglandins (sulprostone in France) may reverse uterine atony." | 3.83 | Major obstetric hemorrhage. ( Le Gouez, A; Mercier, FJ, 2016) |
| " The effectiveness of treatment methods and the optimal dosage of misoprostol are research priorities." | 2.53 | Preventing deaths due to haemorrhage. ( Hofmeyr, GJ; Qureshi, Z, 2016) |
| "Placenta previa affects approximately 4 per 1000 pregnancies and increases the risk of antepartum bleeding, emergent preterm labour and emergency caesarean sections." | 1.91 | Use of tranexamic acid (TXA) to reduce preterm birth and other adverse obstetrical outcomes among pregnant individuals with placenta previa: a systematic review protocol. ( Muldoon, KA; Seguin, N; Visintini, S; Walker, M, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Seguin, N | 1 |
| Visintini, S | 1 |
| Muldoon, KA | 1 |
| Walker, M | 1 |
| Hajmurad, OS | 1 |
| Choxi, AA | 1 |
| Zahid, Z | 1 |
| Dudaryk, R | 1 |
| Abbas, AM | 1 |
| Shady, NW | 1 |
| Sallam, HF | 1 |
| Mauritz, AA | 1 |
| Dominguez, JE | 1 |
| Guinn, NR | 1 |
| Gilner, J | 1 |
| Habib, AS | 1 |
| Hofmeyr, GJ | 1 |
| Qureshi, Z | 1 |
| Le Gouez, A | 1 |
| Mercier, FJ | 1 |
| Valsecchi, A | 1 |
| Cappelletti, M | 1 |
1 review available for tranexamic acid and Placenta Praevia
| Article | Year |
|---|---|
Preventing deaths due to haemorrhage.
Topics: Abruptio Placentae; Antifibrinolytic Agents; Blood Transfusion; Cesarean Section; Crystalloid Soluti | 2016 |
1 trial available for tranexamic acid and Placenta Praevia
| Article | Year |
|---|---|
Bilateral uterine artery ligation plus intravenous tranexamic acid during cesarean delivery for placenta previa: a randomized double-blind controlled trial.
Topics: Administration, Intravenous; Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; | 2019 |
5 other studies available for tranexamic acid and Placenta Praevia
| Article | Year |
|---|---|
Use of tranexamic acid (TXA) to reduce preterm birth and other adverse obstetrical outcomes among pregnant individuals with placenta previa: a systematic review protocol.
Topics: Female; Humans; Infant, Newborn; Obstetric Labor Complications; Placenta; Placenta Previa; Postpartu | 2023 |
Aortoiliac Thrombosis Following Tranexamic Acid Administration During Urgent Cesarean Hysterectomy: A Case Report.
Topics: Adult; Antifibrinolytic Agents; Aorta, Abdominal; Balloon Occlusion; Cesarean Section; Female; Human | 2017 |
Blood-Conservation Strategies in a Blood-Refusal Parturient with Placenta Previa and Placenta Percreta.
Topics: Adult; Bloodless Medical and Surgical Procedures; Combined Modality Therapy; Erythropoietin; Female; | 2016 |
Major obstetric hemorrhage.
Topics: Blood Component Transfusion; Combined Modality Therapy; Dinoprostone; Factor VIIa; Female; Fibrinoge | 2016 |
[Possibilities of the use of an inhibitor of hemolysis (AMCHA), by rectal and vaginal administration, for gynecological hemorrhages].
Topics: Adolescent; Adult; Aged; Blood Coagulation Disorders; Child; Cyclohexanecarboxylic Acids; Female; He | 1975 |